Aytu biopharma to participate in the canaccord genuity 42nd annual growth conference

Englewood, co / accesswire / july 26, 2022 / aytu biopharma, inc. (the "company") (nasdaq:aytu), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that chief executive officer josh disbrow and chief financial officer mark oki will participate in the canaccord genuity 42nd annual growth conference being held august 8-11, 2022 at the intercontinental hotel in boston, ma. the company will conduct one-on-one meetings throughout tuesday, august 9th and wednesday, august 10th and will present a corporate overview at 4:00 p.m.
AYTU Ratings Summary
AYTU Quant Ranking